Novartis job cuts affect hundreds in Swiss manufacturing, while Novo’s diabetes drug advances to Phase 3 trials.
Browsing: Market & Financials
Market trends, financial performance, quarterly results, and investment insights from global pharma and biotech companies.
Big Pharma CEO ratings reveal employee approval levels, highlighting leadership impact on companies.
QurAlis hires Manoj Malhotra as Chief Medical Officer, leveraging his experience from AbbVie to strengthen its leadership.
Mark Cuban discusses drug pricing challenges in biotech, highlighting potential impacts on the industry.
Recursion leadership change sees Najat Khan taking over as CEO, focusing on AI-driven drug development results.
Eli Lilly $1 Trillion market value milestone achieved through obesity drug success, surpassing peers.
Pfizer settlement Texas involves $41.5 million payment over ADHD drug manufacturing flaws.
Moderna $1.5B investment aims to expand its vaccine franchise and achieve breakeven by 2028.
Scott Gottlieb joins UnitedHealth’s board, enhancing regulatory ties.
Sanofi AI ROI is about measurable improvements, not flashy demos, says CEO Paul Hudson.